Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Nymox Pharmaceutical Corp. (NASDAQ: NYMX).

Full DD Report for NYMX

You must become a subscriber to view this report.


Recent News from (NASDAQ: NYMX)

NYMOX Announces Expanded Marketing Plans
HASBROUCK HEIGHTS, N.J., July 02, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) announced today that following the recently announced increased manufacturing capabilities, the Company has formally decided to expand its European marketing plans for Fexapotide Triflu...
Source: GlobeNewswire
Date: July, 02 2018 09:30
Midday Gainers / Losers (06/25/2018)
Gainers : XRM +100% . XBIO +96% . YECO +69% . ABIL +66% . TSRI +33% . LGCYO +32% . ATV +31% . CADC +20% . LGCYP +18% . VLRX +17% . More news on: Xerium Technologies, Inc., Xenetic Biosciences, Inc., Yulong Eco-Materials, Stocks on the move, , Read more ....
Source: SeekingAlpha
Date: June, 25 2018 12:41
Nymox ramps up manufacturing of fexapotide triflutate; shares up 4%
Thinly traded micro cap Nymox Pharmaceutical ( NYMX +4.2% ) announces that it has achieved manufacturing scale-up milestones for lead drug fexapotide triflutate, increasing both batch size and yield. More news on: Nymox Pharmaceutical Corporation, Healthcare stocks news, Stocks on the ...
Source: SeekingAlpha
Date: June, 07 2018 11:06
NYMOX Successfully Achieves Manufacturing Scale-Up
HASBROUCK HEIGHTS, N.J., June 07, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) is pleased to report that manufacturing scale-up milestones have been reached for the Company's lead compound Fexapotide Triflutate (FT). Over the past year, the Company has worked...
Source: GlobeNewswire
Date: June, 07 2018 09:30

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-131.701.6851.721.6540,593
2018-12-121.711.681.721.6744,756
2018-12-111.671.691.701.616156,621
2018-12-101.771.641.771.6062,076
2018-12-071.731.721.761.6080,222

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-136,63226,38925.1317Cover
2018-12-1212,95120,19664.1266Short
2018-12-112,13715,89313.4462Cover
2018-12-1011,90322,22053.5689Short
2018-12-0715,07225,16259.8998Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NYMX.


About Nymox Pharmaceutical Corp. (NASDAQ: NYMX)

Logo for Nymox Pharmaceutical Corp. (NASDAQ: NYMX)

Not available

 

Contact Information

 

 

Current Management

  • Paul Averback / President, CEO
  • Roy M. Wolvin / CFO, Secretary

Current Share Structure

  • Market Cap: $213,109,997 - 05/18/2018
  • Issue and Outstanding: 56,378,306 - 12/31/2017

 


Recent Filings from (NASDAQ: NYMX)

Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 13 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 15 2018
Amendment to a previously filed 20-F
Filing Type: 20-F/AFiling Source: edgar
Filing Date: May, 11 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: April, 26 2018
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: March, 30 2018
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: December, 04 2017
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: November, 06 2017
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: August, 08 2017
Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act
Filing Type: 6-KFiling Source: edgar
Filing Date: May, 16 2017
Annual and transition report of foreign private issuers under sections 13 or 15(d)
Filing Type: 20-FFiling Source: edgar
Filing Date: March, 31 2017

 

 


Daily Technical Chart for (NASDAQ: NYMX)

Daily Technical Chart for (NASDAQ: NYMX)


Stay tuned for daily updates and more on (NASDAQ: NYMX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NYMX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NYMX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NYMX and does not buy, sell, or trade any shares of NYMX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/